IGC

IGC Pharma (IGC)

IGC Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:IGC

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/18	21:00	Business Wire	IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment	AMEX:IGC	IGC Pharma Inc
2024/09/04	21:00	Business Wire	IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/08/27	08:00	Business Wire	IGC Announces Results of its 2024 Annual Stockholders Meeting	AMEX:IGC	IGC Pharma Inc
2024/08/22	22:00	Business Wire	IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/08/20	21:00	Business Wire	IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist	AMEX:IGC	IGC Pharma Inc
2024/08/15	05:23	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	AMEX:IGC	IGC Pharma Inc
2024/08/09	10:30	Business Wire	IGC Pharma Reports First Quarter Fiscal 2025 Results	AMEX:IGC	IGC Pharma Inc
2024/08/08	05:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:IGC	IGC Pharma Inc
2024/08/03	03:38	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:IGC	IGC Pharma Inc
2024/07/18	22:00	Business Wire	IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target	AMEX:IGC	IGC Pharma Inc
2024/07/10	03:17	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:IGC	IGC Pharma Inc
2024/07/09	22:10	Business Wire	Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile	AMEX:IGC	IGC Pharma Inc
2024/07/09	05:07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:IGC	IGC Pharma Inc
2024/06/25	22:00	Business Wire	IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease	AMEX:IGC	IGC Pharma Inc
2024/06/25	08:30	Business Wire	IGC Reports Financial Results for Fiscal Year Ended March 31, 2024	AMEX:IGC	IGC Pharma Inc
2024/06/18	22:00	Business Wire	IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets	AMEX:IGC	IGC Pharma Inc
2024/06/10	22:00	Business Wire	IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol	AMEX:IGC	IGC Pharma Inc
2024/05/28	22:00	Business Wire	IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1	AMEX:IGC	IGC Pharma Inc
2024/05/22	10:20	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:IGC	IGC Pharma Inc
2024/05/22	03:00	Business Wire	IGC Pharma to Attend BIO International Convention 2024	AMEX:IGC	IGC Pharma Inc
2024/05/14	10:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:IGC	IGC Pharma Inc
2024/05/14	10:53	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:IGC	IGC Pharma Inc
2024/04/16	20:00	Business Wire	IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two	AMEX:IGC	IGC Pharma Inc
2024/04/09	22:00	Business Wire	IGC Pharma Adds Advisor in Artificial Intelligence	AMEX:IGC	IGC Pharma Inc
2024/03/27	04:00	Business Wire	IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock	AMEX:IGC	IGC Pharma Inc
2024/03/21	00:00	Business Wire	IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	AMEX:IGC	IGC Pharma Inc
2024/03/20	20:00	Business Wire	IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024	AMEX:IGC	IGC Pharma Inc
2024/03/13	04:00	Business Wire	IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline	AMEX:IGC	IGC Pharma Inc
2024/02/29	03:00	Business Wire	Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model	AMEX:IGC	IGC Pharma Inc
2024/02/24	02:01	Business Wire	IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target	AMEX:IGC	IGC Pharma Inc